Marek Kiełbiński

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

Jerzy Hołowiecki, Sebastian Grosicki, Sebastian Giebel et al. · Journal of Clinical Oncology · 2012 · 264 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta et al. · European Journal Of Haematology · 2007 · 143 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study

Jerzy Hołowiecki, Małgorzata Krawczyk‐Kuliś, Sebastian Giebel et al. · British Journal of Haematology · 2008 · 143 citations · Full text

Medicine, Hematology, Oncology +17

Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation

Elżbieta Gocek, Marek Kiełbiński, Ewa Marcinkowska · FEBS Letters · 2007 · 55 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

Edyta Pawlak, Iwona Kochanowska, Irena Frydecka et al. · PubMed · 2005 · 43 citations

Life Sciences, Immunology, Autoimmunity +15